This is the authors' abstract. We don't add key points for this paper.
Rapid HCV treatment scale-up to PWID in community settings, whilst maintaining high SVR, is achievable. However, other interventions are required to minimise re-infection; reduce drug-related deaths; and improve post-SVR follow-up testing regionally.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Byrne et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: